Predictors of Multidrug-Resistant Tuberculosis (MDR-TB) in Sudan.
MDR-TB
Predictors
Sudan
Tuberculosis
Journal
Antibiotics (Basel, Switzerland)
ISSN: 2079-6382
Titre abrégé: Antibiotics (Basel)
Pays: Switzerland
ID NLM: 101637404
Informations de publication
Date de publication:
09 Jul 2019
09 Jul 2019
Historique:
received:
12
06
2019
revised:
03
07
2019
accepted:
05
07
2019
entrez:
21
7
2019
pubmed:
22
7
2019
medline:
22
7
2019
Statut:
epublish
Résumé
Multidrug-resistant tuberculosis (MDR-TB) is a global public health threat and burden on the health system. This is especially the case in high tuberculosis (TB) prevalence countries, such as Sudan. Consequently, this study aimed to ascertain the predictors of MDR-TB in Sudan to provide future guidance. An unmatched case-control study to assess the predictors of MDR-TB infections among the Sudanese population was conducted from August 2017 to January 2018 at Abu-Anga referral hospital. Patients' data was gathered from patients' cards and via interviews. A structured pre-validated questionnaire was used to gather pertinent information, which included sociodemographic characteristics and other relevant clinical data. Univariate and multivariate logistic regression analysis was employed to determine the predictors of MDR-TB infection. 76 of the 183 patients interviewed (41.5%) had MDR-TB cases. The independent predictors for MDR-TB were living in rural areas [adjusted odds ratio (aOR) = 3.1 (95% confidence interval (CI): 1.2-8.2)], treatment failure [aOR = 56.9 (10.2-319.2)], and smoking [(aOR = 4 (1.2-13.2)], whereas other sociodemographic factors did not predict MDR-TB. In conclusion, the study showed that a history of smoking, living in rural areas, and a previous treatment failure were the predictors of MDR-TB in Sudan. The latter factors are most likely due to issues that are related to access and adherence to treatment and lifestyle. The existence of any of these factors among newly diagnosed TB patients should alert clinicians for the screening of MDR-TB. The implementation of directly observed treatment (DOT) and health education are crucial in stopping the spread of MDR-TB in Sudan.
Identifiants
pubmed: 31323935
pii: antibiotics8030090
doi: 10.3390/antibiotics8030090
pmc: PMC6783989
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
Asian Pac J Trop Biomed. 2012 Dec;2(12):999-1001
pubmed: 23593582
Clin Infect Dis. 2012 Dec;55(12):1600-7
pubmed: 22942206
J Epidemiol Glob Health. 2017 Dec;7(4):227-233
pubmed: 29110862
Int J Infect Dis. 2015 Oct;39:57-61
pubmed: 26327121
Bangladesh Med Res Counc Bull. 2013 Apr;39(1):34-41
pubmed: 23923410
Tuberc Res Treat. 2017;2017:8340746
pubmed: 28197340
Ann Clin Microbiol Antimicrob. 2018 Jul 3;17(1):30
pubmed: 29970076
Expert Rev Respir Med. 2018 Nov;12(11):979-987
pubmed: 30198358
Caspian J Intern Med. 2013 Fall;4(4):785-9
pubmed: 24294475
East Mediterr Health J. 2017 Aug 20;23(6):408-414
pubmed: 28836653
BMC Public Health. 2015 Jan 29;15:29
pubmed: 25631667
PLoS One. 2013;8(1):e54587
pubmed: 23349933
PLoS One. 2017 Mar 23;12(3):e0174373
pubmed: 28334036
Indian J Public Health. 2011 Jan-Mar;55(1):14-21
pubmed: 21727675
Southeast Asian J Trop Med Public Health. 2015 Jul;46(4):697-706
pubmed: 26867390
PLoS One. 2015 Mar 18;10(3):e0118919
pubmed: 25785451
Infect Drug Resist. 2017 Mar 13;10:91-96
pubmed: 28331350
Kathmandu Univ Med J (KUMJ). 2010 Oct-Dec;8(32):392-7
pubmed: 22610768
Lancet Respir Med. 2017 Mar 15;:null
pubmed: 28344011
BMC Infect Dis. 2011 Aug 16;11:219
pubmed: 21846389
Microbiol Spectr. 2017 Mar;5(2):
pubmed: 28361737
BMC Public Health. 2017 Mar 20;17(1):269
pubmed: 28320351
Int J Tuberc Lung Dis. 2012 Nov;16(11):1529-34
pubmed: 22963934
Confl Health. 2018 May 16;12:18
pubmed: 29785203
PLoS One. 2014 Aug 19;9(8):e105214
pubmed: 25136966
BMC Infect Dis. 2017 Mar 20;17(1):219
pubmed: 28320336
Am J Ther. 2011 Sep;18(5):343-9
pubmed: 20535008
Trop Doct. 2013 Apr;43(2):66-70
pubmed: 23796674
Clin Infect Dis. 2008 Nov 1;47(9):1126-34
pubmed: 18808360
J Glob Infect Dis. 2017 Oct-Dec;9(4):139-145
pubmed: 29302148
Afr Health Sci. 2015 Jun;15(2):368-77
pubmed: 26124781
BMC Public Health. 2016 Jan 16;16:42
pubmed: 26775263
BMC Public Health. 2018 Apr 2;18(1):422
pubmed: 29606112
BMC Public Health. 2015 Jan 21;15:15
pubmed: 25605404
Braz J Infect Dis. 2013 Mar-Apr;17(2):239-46
pubmed: 23477764
BMJ Open. 2011 Nov 28;1(2):e000351
pubmed: 22123922
Pilot Feasibility Stud. 2017 Mar 13;3:15
pubmed: 28293431
Infect Drug Resist. 2017 Jul 11;10:209-213
pubmed: 28744149